Flurry of deal-making surrounds new autoimmunity target

Nature Medicine

Volumn 19, Issue 9, 2013, Pages 1078-1078

  Williams, Sarah C P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RORC PROTEIN, HUMAN;

AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CYTOLOGY; DRUG DEVELOPMENT; DRUG INDUSTRY; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; PRE T LYMPHOCYTE; TH17 CELL; AUTOIMMUNE DISEASE; NOTE;

AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CYTOKINES; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; MOLECULAR TARGETED THERAPY; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PRECURSOR CELLS, T-LYMPHOID; TH17 CELLS;

EID: 84891501796     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0913-1078a     Document Type: Article

References (0)